Ultrasound Evaluation of Superior Mesenteric Artery Measurements in a Healthy Pediatric Population
Launched by ENTE OSPEDALIERO CANTONALE, BELLINZONA · Aug 13, 2020
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Ultrasound Evaluation of Superior Mesenteric Artery Measurements in a Healthy Pediatric Population," is looking to understand the size and shape of the superior mesenteric artery (SMA) in healthy children aged 10 to 15 years. The superior mesenteric artery is an important blood vessel that supplies blood to the intestines. The study is being conducted at multiple locations and involves children who are having abdominal ultrasounds for reasons unrelated to digestive issues.
To participate, children must be between 10 and 15 years old and able to have an abdominal ultrasound without any existing conditions that could affect the results, such as an abdominal mass or severe scoliosis. Participants will simply undergo a routine ultrasound, which is a safe and painless procedure that uses sound waves to create images of the body. This trial is currently recruiting participants, and it offers a chance to contribute to important research that could help improve understanding of SMA conditions in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female children
- • Age ranging from10 to 15 years, included
- • Abdominal ultrasound examination to be performed for indications other than gastrointestinal evaluation
- • Signed Informed Consent
- Exclusion Criteria:
- • Presence of a disease that could distort the anatomy around the SMA (e.g., abdominal mass, lymphadenopathy, severe scoliosis, free abdominal fluid)
- • Oncologic patients at risk of neoplastic cachexia.
About Ente Ospedaliero Cantonale, Bellinzona
Ente Ospedaliero Cantonale (EOC) in Bellinzona is a prominent healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a key sponsor of clinical trials, EOC focuses on fostering innovative healthcare solutions and improving patient outcomes through rigorous scientific inquiry. With a commitment to ethical standards and collaboration, EOC plays an essential role in the development of new therapies and medical practices, leveraging its expertise and resources to contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, Switzerland
Bellinzona, Switzerland
Patients applied
Trial Officials
Marirosa Cristallo Lacalamita, MD
Principal Investigator
Imaging Institute of Southern Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials